[Source: Biospace] – HTG, Inc., provider of the quantitative Nuclease Protection Assay, today announced it has signed a contract with Arizona State University to provide gene expression assay and development services as part of a multi-institutional research program. As the core gene expression technology in the program, HTG’s qNPA technology will be used to build tests that rapidly measure an individual’s level of exposure to radiation in the event of a radiological or nuclear incident.
Arizona State University will lead the $40.8 million program and oversee the research program management, coordination and integration necessary for efficient and effective development of the system. The five-year contract with the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) emphasizes the development of prototypes that would enable testing of thousands of individuals a day, permitting more rapid and effective triage of large numbers of patients than is currently possible. HTG’s contribution to the effort represents approximately $12 million of total program value for the company.
For more information: HTG Announces Sub-Contract with ASU to Assess Radiation Exposure